Cargando…

2077. Fluoroquinolone Usage Reduction in the Outpatient Setting

BACKGROUND: Fluoroquinolones (FQs) are the third most commonly prescribed outpatient antibiotic due to ease of dosing, broad spectrum of activity, and favorable pharmacokinetics. However, since 2016, the Food and Drug Administration (FDA) has released warnings about adverse effects, concluding that...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Kevin, Zahlanie, Yorgo, Ortwine, Jessica, Mang, Norman, Wei, Wenjing, Prokesch, Bonnie C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808917/ http://dx.doi.org/10.1093/ofid/ofz360.1757

Ejemplares similares

1842. Fluoroquinolone Usage Reduction in the Outpatient Setting
por: Mang, Norman, et al.
Publicado: (2018)

Decreased Outpatient Fluoroquinolone Prescribing Using a Multimodal Antimicrobial Stewardship Initiative
por: Lin, Kevin, et al.
Publicado: (2020)

A retrospective review of oral cephalosporins versus fluoroquinolones for the treatment of pyelonephritis
por: Lin, Kevin, et al.
Publicado: (2022)

1459. Oral Cephalosporins vs. Fluoroquinolones for the Empiric Treatment of Acute Uncomplicated Pyelonephritis
por: Lin, Kevin, et al.
Publicado: (2019)

1061. Decreased Utilization of Piperacillin–Tazobactam for Escherichia coli and Klebsiella Bacteremia due to Selective Susceptibility Reporting
por: Zahlanie, Yorgo, et al.
Publicado: (2019)

1347. Improved Antibiotic Prescribing Practices for Respiratory Infections Through Use of Computerized Order Sets and Educational Sessions in Pediatric Clinics
por: Zahlanie, Yorgo, et al.
Publicado: (2020)

Cost-Savings Associated With Delayed Switch To Outpatient Antibiotic Regimen For Patients Requiring Daptomycin Therapy
por: Wei, Wenjing, et al.
Publicado: (2017)

Improved Antibiotic Prescribing Practices for Respiratory Infections Through Use of Computerized Order Sets and Educational Sessions in Pediatric Clinics
por: Zahlanie, Yorgo, et al.
Publicado: (2020)

218. IV to PO Conversion of Antimicrobials: Small Intervention, Big Impact
por: Wei, Wenjing, et al.
Publicado: (2018)

Minimal impact of selective susceptibility reporting on the use of piperacillin-tazobactam for Escherichia coli and Klebsiella bacteremia
por: Zahlanie, Yorgo, et al.
Publicado: (2021)

1491. Standard- vs. High-dose Trimethoprim-Sulfamethoxazole for Stenotrophomonas maltophilia pneumonia
por: Hall, Brenton C, et al.
Publicado: (2020)

2177. Institutional Prevalence of Drug-Resistant Pathogens in Community-Acquired Pneumonia
por: Ding, Helen, et al.
Publicado: (2022)

108. Evaluation of the Impact of Dalbavancin Usage on Clinical Outcomes, Cost-Savings, and Adherence at a Large Safety Net Hospital
por: Wei, Wenjing, et al.
Publicado: (2021)

Immunotherapy – 2077. Allergen specific immunotherapy in allergic conjuntivitis due to dust mite
por: Pawar, Sanjay
Publicado: (2013)

139. Impact of Pharmacist Driven Outpatient Fluoroquinolone Stewardship Initiative in Community Based Setting
por: Norman, Sarah, et al.
Publicado: (2020)

2954. Coordinated Antimicrobial Stewardship Efforts to Produce Sustained Reductions in Outpatient Fluoroquinolone Consumption
por: Frederick, Corey M, et al.
Publicado: (2023)

1936. Implementation of IV Push Antibiotics for OPAT in a Safety Net Hospital Following a National Fluid Shortage
por: Bhavan, Kavita, et al.
Publicado: (2018)

1851. Impact of an Antimicrobial Stewardship Initiative on Fluoroquinolone Utilization in the Outpatient Setting at an Academic Medical Center
por: Lafi, Yousef, et al.
Publicado: (2018)

Evaluation of Dalbavancin Use on Clinical Outcomes, Cost-Savings, and Adherence at a Large Safety Net Hospital
por: Lueking, Richard, et al.
Publicado: (2022)

Impact of a Targeted Fluoroquinolone Restriction on Antimicrobial Usage at Two Community Hospitals
por: Borkowski, Jaime, et al.
Publicado: (2017)

2077. Utility of a Real-Time Spatiotemporal Mapping Surveillance System in Detection of Healthcare-Associated Acute Respiratory Viral Infection Clusters in a Tertiary Healthcare Institution
por: Venkatachalam, Indumathi, et al.
Publicado: (2023)

1008. The Reduction of Fluoroquinolone Prescribing in Rural Vermont Hospitals
por: Smith, Lindsay, et al.
Publicado: (2019)

PReS-FINAL-2077: Lung function evaluation in a juvenile idiopathic arthritis cohort
por: Machado Vaz, I, et al.
Publicado: (2013)

1841. Implementation of an Outpatient Antimicrobial Stewardship Program to Reduce Fluoroquinolone Overprescribing at a Veterans Affairs Medical Center (VAMC)
por: Pilate, Marcy, et al.
Publicado: (2018)

20. Fluoroquinolone and Overall Outpatient Antibiotic Prescribing Trends in Adults, 2011 to 2018
por: Gouin, Katryna A, et al.
Publicado: (2020)

Possible canine source of Streptococcus equi subspecies zooepidemicus causing meningitis in an infant
por: Zahlanie, Yorgo, et al.
Publicado: (2019)

Therapeutic Options for Coronavirus Disease 2019 (COVID-19): Where Are We Now?
por: Bae, Esther Y., et al.
Publicado: (2021)

2077. Assessment of the Clinical Impact of Rapid Identification with Same-Day Phenotypic Antimicrobial Susceptibility Testing (Accelerate Pheno™ System) on the Management of Bloodstream Infections in Adult Patients with Antibiotic Stewardship Intervention: A Retrospective Observational Study
por: Ehren, Kathrin, et al.
Publicado: (2018)

PB2077: POD12 AND POD24 – A NEW SURROGATE MARKER IN MANTLE CELL LYMPHOMA TREATMENT?
por: Freitas, J., et al.
Publicado: (2022)

1401. Minimal Cerebrospinal Concentration of Miltefosine Despite Therapeutic Plasma Levels during the Treatment of Amebic Encephalitis
por: Monogue, Marguerite L, et al.
Publicado: (2019)

The Longitudinal Impact of Private Health Insurance on the Usage of Outpatient Services Among Aging Koreans
por: Kim, Narae
Publicado: (2020)

388. Evaluating Rates of Co- and Secondary Infections in Pediatric Patients with COVID-19 Infections in Relation to Antibiotic Prescribing: An Observational Study
por: Allen, Brian S, et al.
Publicado: (2023)

345. Unaccounted Costs Associated with Different Outpatient Parenteral Antimicrobial Therapy (OPAT) Models of Care
por: Player, Jacob, et al.
Publicado: (2023)

Integrating Harm Reduction into Outpatient Opioid Use Disorder Treatment Settings: Harm Reduction in Outpatient Addiction Treatment
por: Taylor, Jessica L., et al.
Publicado: (2021)

1787. County Level Association Between the Rate of Fluoroquinolone-Resistance Gram Negative Bacteria and Fluoroquinolone Utilization in Kansas
por: Fulmer, Robert D, et al.
Publicado: (2022)

Reduction of Clostridium difficile Infection in a Community Teaching Hospital Associated with Antimicrobial Stewardship Team Interventions on Fluoroquinolone Utilization
por: Politis, Paula, et al.
Publicado: (2017)

221. Save the Quinolones! Impact of a Non-Restrictive Fluoroquinolone Reduction Initiative on Antibiotic Resistance at an Urban Teaching Hospital
por: Smoke, Steven, et al.
Publicado: (2018)

1495. Fluoroquinolone as an Alternative Regimen for Klebsiella pneumoniae Liver Abscess
por: Chuang, Chien, et al.
Publicado: (2019)

330. Survival of HIV-Positive Patients with Hemophagocytic Lymphohistiocytosis
por: Brown, Timothy J, et al.
Publicado: (2019)

1465. Discovering Outpatient Stewardship Targets: An Evaluation of Community Acquired Pneumonia in the Outpatient Setting
por: Wattengel, Bethany, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_froq5t6ku2p4nht00p4f2g6j5s